Greater awareness needed about heart disease in women | AHA: No benefit seen in using cannabis for CVD | Low fasting plasma glucose tied to CVD, mortality
August 6, 2020
PCNA SmartBrief
News about cardiovascular disease prevention and managementSIGN UP ⋅   SHARE
Heart Health News
Women have nontraditional and unique cardiovascular risk factors, and gender-specific risk assessment and management may help improve their cardiovascular outcomes, cardiologist Dr. Nanette Wenger told the American Society for Preventive Cardiology Congress on CVD Prevention. Increased awareness of heart disease in women is needed, Wenger said, and providers must educate the public, especially women, about CV risk factors and stress that basic lifestyle modifications can help reduce.
Full Story: Healio (free registration)/Cardiology Today (7/29) 
LinkedIn Twitter Facebook Email
A scientific statement from the American Heart Association said there is no well-documented evidence showing a benefit to using cannabis to prevent or treat cardiovascular disease. The statement, published in the journal Circulation, said preliminary evidence does indicate, however, that cannabis use may negatively affect the heart and blood vessels.
Full Story: Healio (free registration)/Cardiology Today (8/5) 
LinkedIn Twitter Facebook Email
A study in the journal Diabetes and Vascular Disease Research found that individuals with no diabetes and with low fasting plasma glucose were at higher risk for cardiovascular disease and all-cause mortality, compared with those with normal fasting blood glucose. Based on data from 8,497 study participants, the findings also showed that the association between FPG and CVD and all-cause mortality was stronger among men than women, and that those with diabetic range FPG⩾126 mg/dL had higher odds of suffering from all-cause mortality.
Full Story: Medical Dialogues (8/4) 
LinkedIn Twitter Facebook Email
Earn Your Nursing Degree 100% Online.
There's never been a better time to continue your education. At Maryville University you can choose the path that's right for you. We offer 4 NP programs with 5 concentrations to choose from, as well as RN-BSN and DNP programs. Learn more today.
ADVERTISEMENT:
Emerging Trends
A study found 31% of Hispanic/Latino patients with peripheral artery disease took antiplatelet therapy and 26% were on lipid-lowering treatments, while 57% of those with hypertension were taking antihypertensive therapy, researchers reported in the Journal of the American Heart Association. Patients with PAD and coronary artery disease were more likely to take antiplatelet therapy and a statin than those with PAD alone were.
Full Story: Physician's Briefing/HealthDay News (8/5) 
LinkedIn Twitter Facebook Email
Data from almost 5 million patients with a history of stroke found 37.1% had uncontrolled blood pressure, and 80.4% in that group were taking antihypertension medication, according to a study published in JAMA Neurology. The most common treatments were angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and beta-blockers.
Full Story: Healio (free registration) (8/4) 
LinkedIn Twitter Facebook Email
Nursing in the News
The proposed 2021 Physician Fee Schedule for Medicare calls for making permanent some telehealth rules created for the novel coronavirus pandemic, along with workforce flexibilities such as allowing nurse practitioners, clinical nurse specialists, and other providers to supervise those performing diagnostic tests. The CMS said the provisions would help ensure "health care professionals can practice at the top of their professional training."
Full Story: RevCycle Intelligence (8/4) 
LinkedIn Twitter Facebook Email
PCNA Update
Join us for a free non-CE learning event on flu and cardiovascular disease. Learn why the flu vaccine is especially important for individuals with a history of atherosclerotic cardiovascular disease and stroke, as well as the complications associated with influenza. We will also discuss vaccine adherence strategies in the era of COVID-19 and provide practical clinical takeaways you can apply as we head into flu season this year. Learn more and register.
LinkedIn Twitter Facebook Email
PCNA is developing a tool to help you manage patients with elevated cholesterol and statin intolerance. Share your experiences and help shape this tool by taking our 3-minute survey. We appreciate your help! Take the survey.
LinkedIn Twitter Facebook Email
LEARN MORE ABOUT PCNA:
Join PCNA | News | Clinical Tools | Conferences & Programs | Contact
Invent a new language anyone can understand.
Lawrence Ferlinghetti,
poet
LinkedIn Twitter Facebook Email
Sharing PCNA SmartBrief with your network keeps the quality of content high and these newsletters free.
Help Spread the Word
SHARE
Or copy and share your personalized link:
smartbrief.com/pcna/?referrerId=eSriBJbAIQ
 
SmartBrief publishes more than 200 free industry newsletters - Browse our portfolio
Sign Up  |    Update Profile  |    Advertise with SmartBrief
Unsubscribe  |    Privacy policy
CONTACT US: FEEDBACK  |    ADVERTISE
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004